Obesity, Gut Microbiota, and Early-Onset Colorectal Cancer
A new review explores the complex relationship between obesity, gut microbiota, and the increasing incidence of early-onset colorectal cance…
GLP-1 is a hormone your gut already makes — and your gut bacteria help trigger it. As GLP-1 drugs reshape medicine, here is the evidence-based map of where the microbiome actually fits, and where the probiotic marketing outruns it.
A new review explores the complex relationship between obesity, gut microbiota, and the increasing incidence of early-onset colorectal cance…
A new review highlights the potential of icariin, a natural compound, in modulating neuroinflammation through the gut-brain axis. The eviden…
A new study explores the use of AI and polygenic risk scores in tailoring obesity interventions, aiming to improve long-term outcomes.
A new review explores the complex genetic architecture of inflammatory bowel disease and the implications for precision medicine.
A new study explores how gut microbiome features mediate the relationship between dietary intake and type 2 diabetes in a Korean population.
A new review highlights the potential of the gut microenvironment to influence immune responses in organ transplantation, suggesting novel s…
A new review examines the role of gut microbiota dysbiosis in Alzheimer's disease, highlighting potential immunopharmacological intervention…
A new study explores how geographic and dietary factors influence the gut microbiome's composition and function across five countries, revea…
A new study investigates the relationship between gastrointestinal symptoms and depression severity among South Indian adults, highlighting …
The research that mattered, the hype that didn’t, and one idea worth carrying around. No spam, unsubscribe anytime.
A new clinical trial protocol investigates the feasibility of using tranexamic acid to prevent anastomotic leaks after rectal cancer surgery…
A new clinical trial investigates the potential benefits of early fecal microbiota transplantation for patients experiencing their first epi…
A new study investigates the combined effects of modified WuMei decoction and Bifidobacterium capsules on patients post-endoscopic resection…
A new review explores the complex relationship between obesity, gut microbiota, and the increasing incidence of early-onset colorectal cance…
A new study explores the use of AI and polygenic risk scores in tailoring obesity interventions, aiming to improve long-term outcomes.
A new review explores the complex genetic architecture of inflammatory bowel disease and the implications for precision medicine.
A new review highlights the potential of icariin, a natural compound, in modulating neuroinflammation through the gut-brain axis. The eviden…
A new review examines the role of gut microbiota dysbiosis in Alzheimer's disease, highlighting potential immunopharmacological intervention…
A new study investigates the relationship between gastrointestinal symptoms and depression severity among South Indian adults, highlighting …
“Live cultures” is becoming a measurable claim. Inside the industry shift from vague probiotics to defined, characterized strains.
GLP-1 is a hormone your gut already makes — and your gut bacteria help trigger it. As GLP-1 drugs reshape medicine, here is the evidence-bas…
One gut bacterium has become the face of “next-generation” probiotics — a defined, characterized strain with human metabolic data and a tant…
A new study suggests that pre-transplant gut microbiome profiles could help predict early acute rejection in kidney transplant recipients, o…
Two sequencing methods sit behind nearly every gut test on the market, and they don’t read the same book. One tells you roughly who is there…
A 2026 NIST study found direct-to-consumer microbiome tests so inconsistent that the noise between brands rivaled the real biological differ…